Lab-Grown immune cells tested as new weapon against aggressive leukemia
NCT ID NCT05712278
Summary
This early-stage study tested a new treatment called SAR445419, which uses 'off-the-shelf' natural killer (NK) cells—a type of immune cell made in a lab. It was given to a small group of adults whose acute myeloid leukemia had returned or did not respond to prior treatments. The main goals were to find a safe dose and see how well the body tolerates these cells after a short course of chemotherapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKAEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Albert Einstein College of Medicine Site Number : 8400001
The Bronx, New York, 10461, United States
-
University of Nebraska Medical Center Site Number : 8400003
Omaha, Nebraska, 68198-2168, United States
-
~MD Anderson Cancer Center Site Number : 8400002
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.